A monocarboxylate transporter rescues frontotemporal dementia and Alzheimer's disease models.
Brains are highly metabolically active organs, consuming 20% of a person's energy at resting state. A decline in glucose metabolism is a common feature across a number of neurodegenerative diseases. Another common feature is the progressive accumulation of insoluble protein deposits, it's...
Main Authors: | Dongwei Xu, Alec Vincent, Andrés González-Gutiérrez, Benjamin Aleyakpo, Sharifah Anoar, Ashling Giblin, Magda L Atilano, Mirjam Adams, Dunxin Shen, Annora Thoeng, Elli Tsintzas, Marie Maeland, Adrian M Isaacs, Jimena Sierralta, Teresa Niccoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-09-01
|
Series: | PLoS Genetics |
Online Access: | https://doi.org/10.1371/journal.pgen.1010893 |
Similar Items
-
A monocarboxylate transporter rescues frontotemporal dementia and Alzheimer’s disease models
by: Dongwei Xu, et al.
Published: (2023-09-01) -
Mitochondria Dysfunction in Frontotemporal Dementia/Amyotrophic Lateral Sclerosis: Lessons From Drosophila Models
by: Sharifah Anoar, et al.
Published: (2021-11-01) -
Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration
by: Sarah Mizielinska, et al.
Published: (2017-04-01) -
Exploring monocarboxylate transporter inhibition for cancer treatment
by: Tomas Koltai, et al.
Published: (2024-02-01) -
Distribution of Monocarboxylate Transporters in Brain and Choroid Plexus Epithelium
by: Masaki Ueno, et al.
Published: (2023-07-01)